The antimicrobial peptide DGL13K is active against resistant gram-negative bacteria and subinhibitory concentrations stimulate bacterial growth without causing resistance
Gorr, S.-U.; Brigman, H. V.; Anderson, J. C.; Hirsch, E. B.
10.1101/2020.05.08.085282 bioRxivShow abstract
Antimicrobial peptides may be alternatives to traditional antibiotics with reduced bacterial resistance. The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2. This study determined the relative activity of the L-and D-enantiomers of GL13K to wild-type and drug-resistant strains of three gram-negative species and against Pseudomonas aeruginosa biofilms. DGL13K displayed in vitro activity against ESBL and KPC-producing Klebsiella pneumoniae (MICs 16-32 g/ml), MDR and XDR P. aeruginosa, and XDR Acinetobacter baumannii carrying metallo-beta-lactamases (MICs 8-32 g/ml). P. aeruginosa showed low inherent resistance to DGL13K and the increased metabolic activity and growth caused by sub-MIC concentrations of GL13K peptides did not result in acquired bacterial resistance. Daily dosing for approximately two weeks did not increase the MIC of DGL13K or cause cross-resistance between LGL13K and DGL13K. These data suggest that DGL13K is a promising candidate antimicrobial peptide for further development.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates 93%
- Methicillin-Resistant Staphylococcus aureus has Phenotypic Variation in mecA Expression that Alters Antibiotic Sensitivity 93%
- Differential response of Candida species morphologies and isolates to fluconazole and boric acid 93%
Similar papers in this journal
- Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin Against Cystic Fibrosis Pseudomonas aeruginosa 95%
- Evaluating mono and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the Hollow-Fiber Infection Model 94%
- SET-M33 peptide as a selective in vitro antimicrobial agent against the porcine respiratory pathogen Glaesserella parasuis 94%
Similar papers in this journal
- Development of a polymicrobial checkerboard assay as a tool for determining combinatorial antibiotic effectiveness in polymicrobial communities 92%
- Tamoxifen repurposing to combat infections by multidrug-resistant Gram-negative bacilli 92%
- Trans -cinnamaldehyde attenuates Enterococcus faecalis virulence and inhibits biofilm formation 91%
Similar papers in this journal
- Antimicrobial activity of cationic antimicrobial peptides against stationary phase bacteria 96%
- Brevibacillin 2V, a novel antimicrobial lipopeptide with an exceptional low hemolytic activity 94%
- Responses of carbapenemase-producing and non-producing carbapenem-resistant Pseudomonas aeruginosa strains to meropenem revealed by quantitative tandem mass spectrometry proteomics 93%
Similar papers in this journal
- Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability 93%
- Assessment of Phenotype Microarray plates for rapid and high-throughput analysis of collateral sensitivity networks 93%
- Stability of β-lactam antibiotics in bacterial growth media 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.